127 related articles for article (PubMed ID: 30221408)
21. Impact of censoring data below an arbitrary quantification limit on structural model misspecification.
Byon W; Fletcher CV; Brundage RC
J Pharmacokinet Pharmacodyn; 2008 Feb; 35(1):101-16. PubMed ID: 17963024
[TBL] [Abstract][Full Text] [Related]
22. Censored correlated cytokine concentrations: multivariate Tobit regression using clustered variance estimation.
Andersen A; Benn CS; Jørgensen MJ; Ravn H
Stat Med; 2013 Jul; 32(16):2859-74. PubMed ID: 23212926
[TBL] [Abstract][Full Text] [Related]
23. Maximum likelihood estimates of mean and variance of occupation radiation doses subjected to minimum detection levels.
Datta D; Singh S; Johnson BE; Kushwaha HS
Radiat Prot Dosimetry; 2008; 129(4):411-8. PubMed ID: 18083720
[TBL] [Abstract][Full Text] [Related]
24. Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses.
Keizer RJ; Jansen RS; Rosing H; Thijssen B; Beijnen JH; Schellens JH; Huitema AD
Pharmacol Res Perspect; 2015 Mar; 3(2):e00131. PubMed ID: 26038706
[TBL] [Abstract][Full Text] [Related]
25. Sufficient dimension reduction for censored predictors.
Tomassi D; Forzani L; Bura E; Pfeiffer R
Biometrics; 2017 Mar; 73(1):220-231. PubMed ID: 27506481
[TBL] [Abstract][Full Text] [Related]
26. Penalized partial likelihood regression for right-censored data with bootstrap selection of the penalty parameter.
Huang J; Harrington D
Biometrics; 2002 Dec; 58(4):781-91. PubMed ID: 12495132
[TBL] [Abstract][Full Text] [Related]
27. Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data.
Yang S; Roger J
Pharm Stat; 2010; 9(4):313-30. PubMed ID: 20043295
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of regression methods when immunological measurements are constrained by detection limits.
Uh HW; Hartgers FC; Yazdanbakhsh M; Houwing-Duistermaat JJ
BMC Immunol; 2008 Oct; 9():59. PubMed ID: 18928527
[TBL] [Abstract][Full Text] [Related]
29. Evaluating Left-Censored Data Through Substitution, Parametric, Semi-parametric, and Nonparametric Methods: A Simulation Study.
Tekindal MA; Erdoğan BD; Yavuz Y
Interdiscip Sci; 2017 Jun; 9(2):153-172. PubMed ID: 26590921
[TBL] [Abstract][Full Text] [Related]
30. Nonparametric estimation of a delay distribution based on left-censored and right-truncated data.
Cui J
Biometrics; 1999 Jun; 55(2):345-9. PubMed ID: 11318186
[TBL] [Abstract][Full Text] [Related]
31. Limitations of maximum likelihood estimation procedures when a majority of the observations are below the limit of detection.
Jain RB; Wang RY
Anal Chem; 2008 Jun; 80(12):4767-72. PubMed ID: 18489183
[TBL] [Abstract][Full Text] [Related]
32. A multiple imputation approach to Cox regression with interval-censored data.
Pan W
Biometrics; 2000 Mar; 56(1):199-203. PubMed ID: 10783796
[TBL] [Abstract][Full Text] [Related]
33. A new statistical test for latent class in censored data due to detection limit.
Zou Y; Peng Z; Cornell J; Ye P; He H
Stat Med; 2021 Feb; 40(3):779-798. PubMed ID: 33159355
[TBL] [Abstract][Full Text] [Related]
34. Bivariate Left-Censored Measurements in Biomonitoring: A Bayesian Model for the Determination of Biological Limit Values Based on Occupational Exposure Limits.
Martin Remy A; Wild P
Ann Work Expo Health; 2017 Jun; 61(5):515-527. PubMed ID: 28475797
[TBL] [Abstract][Full Text] [Related]
35. Maximum likelihood inference for left-censored HIV RNA data.
Lynn HS
Stat Med; 2001 Jan; 20(1):33-45. PubMed ID: 11135346
[TBL] [Abstract][Full Text] [Related]
36. Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification.
Chen W; Qian L; Shi J; Franklin M
BMC Med Res Methodol; 2018 Jun; 18(1):63. PubMed ID: 29929477
[TBL] [Abstract][Full Text] [Related]
37. Estimation of variance components for censored data with applications to blood pressure variability.
Smith L; Rosner B
Stat Med; 1991 Sep; 10(9):1441-52. PubMed ID: 1925172
[TBL] [Abstract][Full Text] [Related]
38. Change-point models to estimate the limit of detection.
May RC; Chu H; Ibrahim JG; Hudgens MG; Lees AC; Margolis DM
Stat Med; 2013 Dec; 32(28):4995-5007. PubMed ID: 23784922
[TBL] [Abstract][Full Text] [Related]
39. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of left-censored quantitative outcome: example of procalcitonin level].
Asselineau J; Thiébaut R; Perez P; Pinganaud G; Chêne G
Rev Epidemiol Sante Publique; 2007 Jun; 55(3):213-20. PubMed ID: 17467942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
